Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for BHVN

Stock Name	Biohaven Pharmaceutical Holding Co Ltd
Ticker	BHVN(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	VGG111961055
LEI	5299007STZTNN32O9920

Show aggregate BHVN holdings

News associated with BHVN

Biohaven (NYSE:BHVN) and Celularity (NASDAQ:CELU) Head to Head Analysis: Celularity (NASDAQ:CELU – Get Free Report) and Biohaven (NYSE:BHVN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Volatility and Risk Celularity has a beta of 0.81, […] - 2025-09-17 02:58:44
BTIG Research Forecasts Strong Price Appreciation for Biohaven (NYSE:BHVN) Stock: Biohaven (NYSE:BHVN – Get Free Report) had its price target lifted by equities researchers at BTIG Research from $59.00 to $60.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. BTIG Research’s target price indicates a potential upside of 309.14% from the stock’s previous […] - 2025-08-21 03:06:47
Biohaven (NYSE:BHVN) Price Target Cut to $52.00 by Analysts at Robert W. Baird: Biohaven (NYSE:BHVN – Get Free Report) had its target price reduced by Robert W. Baird from $57.00 to $52.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price objective would indicate a potential upside of 260.86% from the […] - 2025-08-14 02:52:59
Morgan Stanley Has Lowered Expectations for Biohaven (NYSE:BHVN) Stock Price: Biohaven (NYSE:BHVN – Get Free Report) had its target price lowered by Morgan Stanley from $63.00 to $54.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of 274.74% from the stock’s current price. Other […] - 2025-08-14 02:52:54
Bank of America Cuts Biohaven (NYSE:BHVN) Price Target to $49.00: Biohaven (NYSE:BHVN – Get Free Report) had its price objective reduced by investment analysts at Bank of America from $50.00 to $49.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price target would suggest a potential upside of 240.04% from the stock’s previous […] - 2025-08-14 02:52:53
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH: Universal Beteiligungs und Servicegesellschaft mbH trimmed its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 21.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 9,463 shares of the company’s stock after selling 2,569 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Biohaven were worth $227,000 at the […] - 2025-08-05 04:38:55
Wednesday's ETF Movers: XBI, OIH: In trading on Wednesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.8% on the day. Components of that ETF showing particular strength include shares of Replimune Group, up about 104.8% and shares of Biohaven, up about 18.9% on the day. And underperfor - 2025-07-30 14:51:58
Wednesday Sector Leaders: Music & Electronics Stores, Biotechnology Stocks: In trading on Wednesday, music & electronics stores shares were relative leaders, up on the day by about 5.7%. Leading the group were shares of Global Industrial, up about 21.2% and shares of Vertiv Holdings up about 2.3% on the day. Also showing relative strength are biot - 2025-07-30 14:51:45
New York State Common Retirement Fund Has $3.85 Million Holdings in Biohaven Ltd. (NYSE:BHVN): New York State Common Retirement Fund grew its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 589.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 160,251 shares of the company’s stock after purchasing an additional 137,024 shares during the […] - 2025-07-23 06:58:57
Jennison Associates LLC Has $451,000 Stock Position in Biohaven Ltd. (NYSE:BHVN): Jennison Associates LLC lowered its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 80.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,741 shares of the company’s stock after selling 78,791 shares during the quarter. Jennison Associates LLC’s holdings […] - 2025-07-23 06:21:00
Arizona State Retirement System Acquires 1,810 Shares of Biohaven Ltd. (NYSE:BHVN): Arizona State Retirement System grew its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 7.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,655 shares of the company’s stock after purchasing an additional 1,810 shares during the quarter. Arizona State […] - 2025-07-22 08:54:54
Biohaven Ltd. (NYSE:BHVN) Shares Acquired by Sigma Planning Corp: Sigma Planning Corp increased its holdings in Biohaven Ltd. (NYSE:BHVN – Free Report) by 32.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,862 shares of the company’s stock after purchasing an additional 2,661 shares during the quarter. Sigma Planning Corp’s holdings in Biohaven […] - 2025-07-21 05:31:03
Biohaven Ltd. (NYSE:BHVN) Receives $58.46 Average PT from Brokerages: Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been given a consensus recommendation of “Buy” by the fifteen research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating […] - 2025-07-18 02:37:05
Analysts Set Biohaven Ltd. (NYSE:BHVN) Price Target at $58.46: Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been given a consensus rating of “Buy” by the fifteen ratings firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, twelve have issued a buy recommendation and two have given a strong buy […] - 2025-06-23 02:14:04
JPMorgan Chase & Co. Lowers Biohaven (NYSE:BHVN) Price Target to $55.00: Biohaven (NYSE:BHVN – Get Free Report) had its price target reduced by stock analysts at JPMorgan Chase & Co. from $68.00 to $55.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside […] - 2025-06-20 02:56:57
Biohaven (NYSE:BHVN) Reaches New 1-Year Low Following Analyst Downgrade: Biohaven Ltd. (NYSE:BHVN – Get Free Report)’s stock price reached a new 52-week low during trading on Wednesday after JPMorgan Chase & Co. lowered their price target on the stock from $68.00 to $55.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Biohaven traded as low as $14.32 and last traded […] - 2025-06-20 02:08:58
California State Teachers Retirement System Purchases 7,005 Shares of Biohaven Ltd. (NYSE:BHVN): California State Teachers Retirement System lifted its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 10.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,144 shares of the company’s stock after purchasing an additional 7,005 […] - 2025-06-06 05:06:55
Biohaven Ltd. (NYSE:BHVN) Receives $59.46 Consensus Target Price from Analysts: Biohaven Ltd. (NYSE:BHVN – Get Free Report) has been assigned a consensus rating of “Buy” from the fifteen brokerages that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, twelve have given a buy recommendation and two have issued a strong buy recommendation on the company. […] - 2025-05-29 02:27:28
Two Sigma Advisers LP Trims Stake in Biohaven Ltd. (NYSE:BHVN): Two Sigma Advisers LP cut its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 45.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 99,900 shares of the company’s stock after selling 84,300 shares during the quarter. Two Sigma Advisers […] - 2025-05-27 05:24:58
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 13,147 Shares of Biohaven Ltd. (NYSE:BHVN): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 32.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 54,271 shares of the company’s stock after purchasing an additional 13,147 shares […] - 2025-05-22 05:52:58
Nuveen Asset Management LLC Has $34.33 Million Stake in Biohaven Ltd. (NYSE:BHVN): Nuveen Asset Management LLC raised its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 55.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 919,235 shares of the company’s stock after purchasing an additional 326,636 shares during the quarter. Nuveen Asset Management LLC […] - 2025-05-21 05:11:02
Biohaven (NYSE:BHVN) Downgraded to Sector Perform Rating by Royal Bank of Canada: Royal Bank of Canada lowered shares of Biohaven (NYSE:BHVN – Free Report) from an outperform rating to a sector perform rating in a report issued on Monday, Marketbeat reports. They currently have $21.00 price objective on the stock, down from their prior price objective of $54.00. Several other equities analysts have also issued reports on […] - 2025-05-20 02:58:54
Ameriprise Financial Inc. Grows Holdings in Biohaven Ltd. (NYSE:BHVN): Ameriprise Financial Inc. raised its stake in Biohaven Ltd. (NYSE:BHVN – Free Report) by 40.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 508,682 shares of the company’s stock after acquiring an additional 145,331 shares during the period. Ameriprise Financial Inc. owned approximately […] - 2025-05-16 06:02:48
Biohaven (NYSE:BHVN) Stock Price Down 5.3% Following Weak Earnings: Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) traded down 5.3% during trading on Tuesday following a dissappointing earnings announcement. The stock traded as low as $19.33 and last traded at $19.48. 486,099 shares traded hands during mid-day trading, a decline of 58% from the average session volume of 1,169,407 shares. The stock had […] - 2025-05-15 02:40:44
Biohaven Ltd. (NYSE:BHVN) Receives Average Recommendation of “Buy” from Analysts: Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been given a consensus recommendation of “Buy” by the fifteen brokerages that are covering the company, Marketbeat Ratings reports. Fourteen equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 […] - 2025-05-01 02:12:47
Robert W. Baird Has Lowered Expectations for Biohaven (NYSE:BHVN) Stock Price: Biohaven (NYSE:BHVN – Get Free Report) had its price objective reduced by investment analysts at Robert W. Baird from $60.00 to $57.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s target price suggests a potential upside of 160.39% from the […] - 2025-04-30 03:00:48
Biohaven Sees Unusually Large Options Volume (NYSE:BHVN): Biohaven Ltd. (NYSE:BHVN – Get Free Report) saw unusually large options trading on Tuesday. Traders purchased 7,638 call options on the stock. This represents an increase of 588% compared to the typical daily volume of 1,110 call options. Biohaven Trading Up 2.7 % Shares of NYSE:BHVN opened at $21.10 on Wednesday. The company has a […] - 2025-04-23 02:28:49
Barclays PLC Has $14.67 Million Stock Position in Biohaven Ltd. (NYSE:BHVN): Barclays PLC boosted its stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 46.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 392,727 shares of the company’s stock after buying an additional 124,650 shares during the period. Barclays PLC […] - 2025-04-21 06:12:48
Summit Investment Advisors Inc. Has $336,000 Stake in Biohaven Ltd. (NYSE:BHVN): Summit Investment Advisors Inc. increased its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 18.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,985 shares of the company’s stock after acquiring an additional 1,378 shares during the quarter. Summit Investment […] - 2025-04-21 04:56:55
Federated Hermes Inc. Trims Stock Holdings in Biohaven Ltd. (NYSE:BHVN): Federated Hermes Inc. reduced its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 41.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,753 shares of the company’s stock after selling 8,869 shares during the quarter. Federated Hermes Inc.’s holdings […] - 2025-04-18 05:26:52

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc BHVN holdings

Date	Number of BHVN Shares Held	Base Market Value of BHVN Shares	Local Market Value of BHVN Shares	Change in BHVN Shares Held	Change in BHVN Base Value	Current Price per BHVN Share Held	Previous Price per BHVN Share Held
2025-09-30 (Tuesday)	61,345	USD 920,788	USD 920,788
2025-09-29 (Monday)	60,951	USD 893,542	USD 893,542
2025-09-26 (Friday)	60,951	USD 914,265	USD 914,265
2025-09-25 (Thursday)	60,951	USD 842,343	USD 842,343	0	USD 4,876	USD 13.82	USD 13.74
2025-09-24 (Wednesday)	60,951	USD 837,467	USD 837,467
2025-09-17 (Wednesday)	60,557	USD 890,188	USD 890,188	0	USD 73,274	USD 14.7	USD 13.49
2025-09-16 (Tuesday)	60,557	USD 816,914	USD 816,914

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BHVN by Blackrock for IE00B3VWM098

Show aggregate share trades of BHVN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -197 14.680* 28.37 Profit of 5,590 on sale
2025-07-31 BUY 591 15.100* 28.54
2025-07-28 SELL -197 13.050* 28.81 Profit of 5,675 on sale
2025-06-30 SELL -394 14.110* 30.52 Profit of 12,024 on sale
2025-06-25 SELL -197 14.330* 30.86 Profit of 6,079 on sale
2025-06-20 SELL -394 14.460* 31.21 Profit of 12,295 on sale
2025-05-30 BUY 5,912 14.810* 33.07
2025-05-23 BUY 177 15.640* 33.81
2025-05-19 SELL -177 15.750* 34.43 Profit of 6,095 on sale
2025-05-15 SELL -531 15.820* 34.76 Profit of 18,457 on sale
2025-05-12 SELL -177 20.560* 35.16 Profit of 6,223 on sale
2025-05-09 SELL -177 20.240* 35.30 Profit of 6,248 on sale
2025-04-30 SELL -177 22.120* 36.25 Profit of 6,417 on sale
2025-04-24 SELL -354 23.400* 36.84 Profit of 13,042 on sale
2025-04-17 SELL -177 20.370* 37.70 Profit of 6,672 on sale
2025-04-15 SELL -531 18.560* 38.11 Profit of 20,237 on sale
2025-04-14 SELL -534 18.510* 38.33 Profit of 20,466 on sale
2025-04-09 SELL -712 18.670* 39.03 Profit of 27,786 on sale
2025-04-07 SELL -1,246 17.910* 39.53 Profit of 49,258 on sale
2025-04-04 SELL -1,780 18.590* 39.78 Profit of 70,807 on sale
2025-03-31 BUY 178 24.040* 40.38
2025-03-19 SELL -356 28.750* 41.62 Profit of 14,815 on sale
2025-03-14 SELL -1,068 29.150* 42.14 Profit of 45,006 on sale
2025-03-13 SELL -356 28.220* 42.34 Profit of 15,073 on sale
2025-03-12 SELL -6,052 29.410* 42.53 Profit of 257,371 on sale
2025-03-07 SELL -356 29.860* 43.14 Profit of 15,359 on sale
2025-03-06 SELL -537 30.400* 43.34 Profit of 23,273 on sale
2025-03-03 SELL -179 32.060* 43.91 Profit of 7,860 on sale
2025-02-28 SELL -4,380 37.180* 44.02 Profit of 192,824 on sale
2025-02-26 SELL -187 37.180* 44.27 Profit of 8,278 on sale
2025-02-25 SELL -561 36.430* 44.40 Profit of 24,909 on sale
2025-02-18 BUY 935 39.390* 44.99
2025-02-13 BUY 187 41.790* 45.20
2025-02-12 BUY 187 42.120* 45.26
2025-02-11 BUY 561 42.530* 45.32
2025-02-06 BUY 1,683 38.880* 45.77
2025-01-27 BUY 187 39.930* 47.30
2024-12-30 BUY 935 35.780* 48.40
2024-12-06 BUY 748 44.800* 48.88
2024-12-05 BUY 187 43.490* 49.07
2024-12-04 BUY 935 46.060* 49.17
2024-11-29 BUY 935 46.010* 49.70
2024-11-27 BUY 744 46.380* 49.99
2024-11-26 BUY 186 47.280* 50.11
2024-11-21 BUY 930 45.190* 50.86
2024-11-20 BUY 558 46.830* 51.09
2024-11-18 BUY 2,232 45.410* 51.74
2024-11-12 BUY 1,488 50.360* 51.83
2024-11-08 BUY 930 53.470* 51.72
2024-11-07 BUY 2,790 53.090* 51.61
2024-11-06 BUY 372 53.740* 51.43
2024-10-31 BUY 186 49.760* 51.89
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-197	14.680*	28.37 Profit of 5,590 on sale
2025-07-31	BUY	591	15.100*	28.54
2025-07-28	SELL	-197	13.050*	28.81 Profit of 5,675 on sale
2025-06-30	SELL	-394	14.110*	30.52 Profit of 12,024 on sale
2025-06-25	SELL	-197	14.330*	30.86 Profit of 6,079 on sale
2025-06-20	SELL	-394	14.460*	31.21 Profit of 12,295 on sale
2025-05-30	BUY	5,912	14.810*	33.07
2025-05-23	BUY	177	15.640*	33.81
2025-05-19	SELL	-177	15.750*	34.43 Profit of 6,095 on sale
2025-05-15	SELL	-531	15.820*	34.76 Profit of 18,457 on sale
2025-05-12	SELL	-177	20.560*	35.16 Profit of 6,223 on sale
2025-05-09	SELL	-177	20.240*	35.30 Profit of 6,248 on sale
2025-04-30	SELL	-177	22.120*	36.25 Profit of 6,417 on sale
2025-04-24	SELL	-354	23.400*	36.84 Profit of 13,042 on sale
2025-04-17	SELL	-177	20.370*	37.70 Profit of 6,672 on sale
2025-04-15	SELL	-531	18.560*	38.11 Profit of 20,237 on sale
2025-04-14	SELL	-534	18.510*	38.33 Profit of 20,466 on sale
2025-04-09	SELL	-712	18.670*	39.03 Profit of 27,786 on sale
2025-04-07	SELL	-1,246	17.910*	39.53 Profit of 49,258 on sale
2025-04-04	SELL	-1,780	18.590*	39.78 Profit of 70,807 on sale
2025-03-31	BUY	178	24.040*	40.38
2025-03-19	SELL	-356	28.750*	41.62 Profit of 14,815 on sale
2025-03-14	SELL	-1,068	29.150*	42.14 Profit of 45,006 on sale
2025-03-13	SELL	-356	28.220*	42.34 Profit of 15,073 on sale
2025-03-12	SELL	-6,052	29.410*	42.53 Profit of 257,371 on sale
2025-03-07	SELL	-356	29.860*	43.14 Profit of 15,359 on sale
2025-03-06	SELL	-537	30.400*	43.34 Profit of 23,273 on sale
2025-03-03	SELL	-179	32.060*	43.91 Profit of 7,860 on sale
2025-02-28	SELL	-4,380	37.180*	44.02 Profit of 192,824 on sale
2025-02-26	SELL	-187	37.180*	44.27 Profit of 8,278 on sale
2025-02-25	SELL	-561	36.430*	44.40 Profit of 24,909 on sale
2025-02-18	BUY	935	39.390*	44.99
2025-02-13	BUY	187	41.790*	45.20
2025-02-12	BUY	187	42.120*	45.26
2025-02-11	BUY	561	42.530*	45.32
2025-02-06	BUY	1,683	38.880*	45.77
2025-01-27	BUY	187	39.930*	47.30
2024-12-30	BUY	935	35.780*	48.40
2024-12-06	BUY	748	44.800*	48.88
2024-12-05	BUY	187	43.490*	49.07
2024-12-04	BUY	935	46.060*	49.17
2024-11-29	BUY	935	46.010*	49.70
2024-11-27	BUY	744	46.380*	49.99
2024-11-26	BUY	186	47.280*	50.11
2024-11-21	BUY	930	45.190*	50.86
2024-11-20	BUY	558	46.830*	51.09
2024-11-18	BUY	2,232	45.410*	51.74
2024-11-12	BUY	1,488	50.360*	51.83
2024-11-08	BUY	930	53.470*	51.72
2024-11-07	BUY	2,790	53.090*	51.61
2024-11-06	BUY	372	53.740*	51.43
2024-10-31	BUY	186	49.760*	51.89

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BHVN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	294,223	495	720,126	40.9%
2025-09-18	387,178	1,884	882,407	43.9%
2025-09-17	640,122	19,549	1,241,326	51.6%
2025-09-16	269,190	112	555,241	48.5%
2025-09-15	331,505	0	615,071	53.9%
2025-09-12	308,639	0	688,836	44.8%
2025-09-11	273,872	0	648,099	42.3%
2025-09-10	311,927	4,850	757,943	41.2%
2025-09-09	294,398	3,630	547,345	53.8%
2025-09-08	823,967	23,784	1,735,905	47.5%
2025-09-05	630,697	900	1,259,541	50.1%
2025-09-04	306,746	0	484,039	63.4%
2025-09-03	593,904	14	1,189,415	49.9%
2025-09-02	214,971	0	513,953	41.8%
2025-08-29	190,751	139	310,640	61.4%
2025-08-28	192,584	255	327,205	58.9%
2025-08-27	243,821	999	526,630	46.3%
2025-08-26	318,763	331	591,342	53.9%
2025-08-25	453,938	0	855,050	53.1%
2025-08-22	949,525	238	1,899,402	50.0%
2025-08-21	198,530	250	443,368	44.8%
2025-08-20	223,489	679	389,590	57.4%
2025-08-19	777,804	0	1,094,207	71.1%
2025-08-18	369,776	0	724,624	51.0%
2025-08-15	499,430	1,961	1,263,187	39.5%
2025-08-14	194,448	0	381,467	51.0%
2025-08-13	472,227	0	785,823	60.1%
2025-08-12	553,667	25,530	842,780	65.7%
2025-08-11	721,941	36,511	1,144,406	63.1%
2025-08-08	615,386	9	972,651	63.3%
2025-08-07	268,512	14	450,807	59.6%
2025-08-06	390,390	0	553,805	70.5%
2025-08-05	382,768	42	506,953	75.5%
2025-08-04	232,136	1	386,776	60.0%
2025-08-01	422,630	0	761,799	55.5%
2025-07-31	429,933	0	1,033,685	41.6%
2025-07-30	1,269,032	1,788	3,226,413	39.3%
2025-07-29	246,682	165	700,973	35.2%
2025-07-28	208,289	3,750	747,637	27.9%
2025-07-25	160,047	81	494,495	32.4%
2025-07-24	104,788	0	405,904	25.8%
2025-07-23	130,255	0	588,414	22.1%
2025-07-22	156,194	500	489,468	31.9%
2025-07-21	202,539	0	478,565	42.3%
2025-07-18	235,005	0	643,071	36.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE